The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Sequential curative surgery and outcome in a multicenter randomized phase III trial comparing conversion chemotherapy followed by chemoradiotherapy vs continuous chemotherapy in patients with unresectable pancreatic cancer (CONKO-007 trial).
 
Sabine Semrau
No Relationships to Disclose
 
Robert Grützmann
No Relationships to Disclose
 
Michael Ghadimi
No Relationships to Disclose
 
Uwe Wittel
Travel, Accommodations, Expenses - Advanced Medical Solutions Limited
 
Lutz Jacobasch
Consulting or Advisory Role - Abbvie (Inst); BeiGene (Inst); Bristol-Myers Squibb/Pfizer (Inst); Incyte (Inst)
Travel, Accommodations, Expenses - Abbvie; Boehringer Ingelheim; Boehringer Ingelheim; Daiichi Sankyo/Astra Zeneca; Ipsen; Sanofi
 
Waldemar Uhl
No Relationships to Disclose
 
Roland Croner
No Relationships to Disclose
 
Wolf Bechstein
Honoraria - Deutscher Ärzteverlag; Plantec GmbH
Travel, Accommodations, Expenses - Asklepios Kliniken; Medupdate
 
Dirk Waldschmidt
Speakers' Bureau - AstraZeneca; Bayer Germany; BMS GmbH & Co. KG; Eisai Germany; Falk Pharma; Incyte
Travel, Accommodations, Expenses - AstraZeneca; BMS GmbH & Co. KG; Eisai; Ipsen; Roche
 
Stefan Boeck
Honoraria - MSD Oncology; SERVIER
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb/Celgene; MSD Oncology; Otsuka; SERVIER
Travel, Accommodations, Expenses - Lilly
 
Nicolas Moosmann
Travel, Accommodations, Expenses - AOP Health
 
Anke Reinacher-Schick
Honoraria - MCI Group; MSD; Pierre Fabre; Roche
Consulting or Advisory Role - Amgen; AstraZeneca; Aurikamed; Boehringer Ingelheim; Daiichi Sankyo; MCI Deutschland; Pierre Fabre; Roche; Servier
Research Funding - AIO-Studien (Inst); BioNTech (Inst); Genentech (Inst); Georg-August-Universität Göttingen (UMG) (Inst); Rafael Pharmaceuticals (Inst); Roche (Inst)
Travel, Accommodations, Expenses - MCI Deutschland; MSD; Pierre Fabre; Roche
 
Henriette Golcher
No Relationships to Disclose
 
Werner Adler
No Relationships to Disclose
 
Annett Kallies
No Relationships to Disclose
 
Markus Hecht
Honoraria - AstraZeneca; Bristol-Myers Squibb; Merck Serono; MSD; Sanofi; Varian Medical Systems
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Merck Serono; MSD; Sanofi; Varian Medical Systems
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; Merck Serono; MSD; Sanofi; Varian Medical Systems
Research Funding - AstraZeneca (Inst); MSD (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Merck Serono
 
Andrea Tannapfel
Honoraria - Amgen; Falk Foundation; Med Update; Merck; Pfizer
 
Benjamin Frey
No Relationships to Disclose
 
Helmut Oettle
Travel, Accommodations, Expenses - SERVIER
 
Rainer Fietkau
Honoraria - AstraZeneca; Merck Serono; Merck Serono; Merck Sharp & Dohme; MSD Oncology; Novocure; Sennewald GmbH; Siemens Healthineers
Consulting or Advisory Role - AstraZeneca; Merck; Merck Serono; MSD Oncology; Novocure
Speakers' Bureau - AstraZeneca; Merck Serono; MSD; Novocure; Sennewald GmbH
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Debios (Inst); Merck (Inst); Merck Serono (Inst); MSD Oncology (Inst); Novocure (Inst); Siemens Healthineers (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Merck; Merck Serono; MSD Oncology; Novocure; Sennewald GmbH